Abcellera Biologics Inc (ABCL)

Mar 04, 2026

AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says - MarketBeat

Mar 04, 2026

Mar 04, 2026

AbCellera at TD Cowen Conference: Strategic Pipeline Insights By Investing.com - Investing.com Canada

Mar 04, 2026

Mar 03, 2026

DNB Asset Management AS Buys Shares of 656,208 AbCellera Biologics Inc. $ABCL - MarketBeat

Mar 03, 2026

Mar 02, 2026

Holdings Thermopylae Increases Stake in AbCellera Biologics Inc - GuruFocus

Mar 02, 2026

Mar 02, 2026

Thermopylae adds AbCellera (ABCL) shares in open-market buy - Stock Titan

Mar 02, 2026

Feb 28, 2026

AbCellera (ABCL) Is Up 18.8% After Pivoting To Clinical Stage And Filing Share Offering - simplywall.st

Feb 28, 2026

Feb 27, 2026

Thermopylae Holdings adds AbCellera (ABCL) shares in $3.27 open-market buy - Stock Titan

Feb 27, 2026

Feb 27, 2026

AbCellera Biologics Inc. (ABCL) Investor Outlook: Analyzing The 155% Upside Potential - DirectorsTalk Interviews

Feb 27, 2026

Feb 27, 2026

A Look At AbCellera Biologics (ABCL) Valuation After Narrower Losses And Pipeline Progress - simplywall.st

Feb 27, 2026

Feb 27, 2026

Decoding AbCellera Biologics Inc (ABCL): A Strategic SWOT Insigh - GuruFocus

Feb 27, 2026

Feb 26, 2026

Why AbCellera (ABCL) Is Up 11.5% After Narrowing Losses And Expanding ESOP Share Capacity – And What's Next - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M - Insider Monkey

Feb 26, 2026

Feb 26, 2026

Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks - TipRanks

Feb 26, 2026

Feb 25, 2026

AbCellera Biologics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 25, 2026

Feb 25, 2026

AbCellera Biologics (ABCL) Q4 Loss Narrows To US$0.03 EPS And Tests Bearish Narratives - simplywall.st

Feb 25, 2026

Feb 25, 2026

AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts - TipRanks

Feb 25, 2026

Feb 25, 2026

ABCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026

Feb 25, 2026

AbCellera Reports Full Year 2025 Business Results - BioSpace

Feb 25, 2026

Feb 25, 2026

Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 25, 2026

Feb 25, 2026

What Sparked AbCellera Biologics To Soar Over 9% After Hours - Bitget

Feb 25, 2026

Feb 25, 2026

AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - GuruFocus

Feb 25, 2026

Feb 24, 2026

AbCellera Biologics Inc. (ABCL) reports Q4 loss, tops revenue estimates - MSN

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ABCL) 2026-02-24 - Seeking Alpha

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Q4 Earnings Call Highlights - MarketBeat

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Inc (NASDAQ:ABCL) Reports Narrower-Than-Expected Loss on Patent Settlement Windfall - ChartMill

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics (NASDAQ:ABCL) Posts Earnings Results, Beats Estimates By $0.15 EPS - MarketBeat

Feb 24, 2026

Feb 24, 2026

Abcellera Biologics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 24, 2026

Feb 24, 2026

AbCellera (ABCL) Achieves Remarkable Revenue Growth in FY25 - GuruFocus

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Inc. SEC 10-K Report - TradingView

Feb 24, 2026

Feb 24, 2026

Abcellera Biologics earnings missed by $0.35, revenue topped estimates - Investing.com South Africa

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Q4 Earnings Report: What Investors Need to Know - Benzinga

Feb 24, 2026

Feb 24, 2026

AbCellera (NASDAQ: ABCL) 2025 results show revenue jump and strong liquidity - Stock Titan

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Feb 24, 2026

Feb 24, 2026

Earnings Scheduled For February 24, 2026 - Benzinga

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics (ABCL) Set to Announce FY Earnings - GuruFocus

Feb 24, 2026

Feb 24, 2026

AbCellera Biologics FY 2025 earnings preview - MSN

Feb 24, 2026

Feb 23, 2026

AbCellera Biologics's Earnings Outlook - Benzinga

Feb 23, 2026

Feb 23, 2026

AbCellera Biologics Inc (ABCL) Misses Q4 2025 Earnings Estimates — EPS $-0.19 vs $-0.16 Expected - AlphaStreet

Feb 23, 2026

Feb 22, 2026

AbCellera Biologics Faces Stock Volatility Amid Strategic Decisions - timothysykes.com

Feb 22, 2026

Feb 21, 2026

AbCellera Biologics Inc (ABCL) down 23% since Q3 2025 results - MSN

Feb 21, 2026

Feb 21, 2026

Is AbCellera Biologics Inc affected by consumer sentimentJuly 2025 Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn

Feb 21, 2026

Feb 20, 2026

AbCellera Biologics Inc. (ABCL) Investor Outlook: Potential Upside of 205% Amidst Biotech Innovations - DirectorsTalk Interviews

Feb 20, 2026

Feb 18, 2026

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Feb 18, 2026

Feb 17, 2026

AbCellera Biologics (ABCL) Projected to Post Earnings on Tuesday - MarketBeat

Feb 17, 2026

Feb 15, 2026

Aug Mood: Is AbCellera Biologics Inc a potential multi baggerJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn

Feb 15, 2026

Feb 14, 2026

AbCellera Biologics (NASDAQ:ABCL) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Feb 14, 2026

Feb 13, 2026

AbCellera Biologics (NASDAQ:ABCL) Trading Up 8.3%Still a Buy? - MarketBeat

Feb 13, 2026

Feb 12, 2026

How resilient is AbCellera Biologics Inc. stock in market downturnsJuly 2025 Weekly Recap & Daily Entry Point Alerts - mfd.ru

Feb 12, 2026

Feb 12, 2026

State of Michigan Retirement System Acquires 350,775 Shares of AbCellera Biologics Inc. $ABCL - MarketBeat

Feb 12, 2026